G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL

This publication has 19 references indexed in Scilit:

• High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults
  Journal of Clinical Oncology, 2017
• High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL
  Leukemia, 2016
• Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 2016
• Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
  Drug Design, Development and Therapy, 2016
• Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 2014
• Both G3BP1 and G3BP2 contribute to stress granule formation
  Genes to Cells, 2012
• Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
  Cancer Cell, 2012
• A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
  The Lancet Oncology, 2009
• Deletion ofIKZF1and Prognosis in Acute Lymphoblastic Leukemia
  New England Journal of Medicine, 2009
• The Arf Tumor Suppressor in Acute Leukemias: Insights from Mouse Models of Bcr–Abl-Induced Acute Lymphoblastic Leukemia
  2007